These data suggest that S1P1 signaling induces the production of TGF-β and IL-10 and that this induction is associated with the activation of TGF-β signaling in BC-derived cells and leads to the expansion of Tregs in tumor microenvironments (Fig. 4c). The gene discussed is S1PR1; the disease is breast cancer.